Shopping Cart
- Remove All
- Your shopping cart is currently empty
LOM612 is a potent and specific FOXO relocator that induces nuclear translocation of the FOXO3a reporter protein as well as endogenous FOXO3a and FOXO1 in a dose-dependent manner in U2OS cells, down-regulates the expression of c-Myc and cyclin D1, and has anti-proliferative effects in human cancer cell lines.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,110 | 6-8 weeks | |
50 mg | $1,450 | 6-8 weeks | |
100 mg | $2,280 | 6-8 weeks | |
1 mL x 10 mM (in DMSO) | $318 | 6-8 weeks |
Description | LOM612 is a potent and specific FOXO relocator that induces nuclear translocation of the FOXO3a reporter protein as well as endogenous FOXO3a and FOXO1 in a dose-dependent manner in U2OS cells, down-regulates the expression of c-Myc and cyclin D1, and has anti-proliferative effects in human cancer cell lines. |
Targets&IC50 | FOXO:1.5 μM (EC50) |
In vitro | LOM612 is cytotoxic to HepG2 cells, with an IC50 value of 0.64 μM, and does not sensitize non-cancer THLE2 cells (IC50, 2.76 μM).LOM612 potently activates nuclear translocation of FOXO with an EC50 value of 1.5 μM, and this effect is independent of CRM-1. LOM612 effectively induces translocation of endogenous FOXO3a and FOXO1, and increases the expression of the FOXO target genes p27 and FasL. LOM612 shows no effect on the nuclear export of endogenous NFKB2 transcription factor in U2OS cells. [1] |
In vivo | LOM612 suppressed tumor growth in MCF-7 cell-derived xenograft mouse models by promoting FOXO1 nuclear localization, downregulating c-Myc and cyclin D1 expression, and showed enhanced antitumor efficacy when combined with selinexor.[2] |
Alias | LOM 612 |
Molecular Weight | 258.3 |
Formula | C13H10N2O2S |
Cas No. | 2173232-79-4 |
Smiles | O=C1C=2SN=C(C2C(=O)C=3C=CC=CC13)N(C)C |
Relative Density. | 1.436 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: < 1 mg/mL (insoluble), Sonication is recommended. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.